Alzheimer's & Dementia
Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease
Trial in peopleBiomarkers
Papers by Emily C. Collins
9 results
- AAIC 2025 Abstract
Characterizing early symptomatic AD patients by visual and quantitative tau profiles
Trial in peoplePopulations - AAIC 2025 Abstract
Implementation of task‐based fMRI in TRAILBLAZER‐ALZ 6 Phase 3b study: Methodological considerations
Trial in peopleBiomarkers
- AAIC 2025 Abstract
Association of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of Donanemab
Trial in peopleBiomarkers - AAIC 2025 Abstract
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
Study in peopleBiomarkers - AAIC 2025 Abstract
Association of Occipital Amyloid PET Burden with ARIA‐E: Exploratory Analyses in Three Clinical Trials of Donanemab
Trial in peopleBiomarkers - AAIC 2025 Abstract
Implementation of task‐based fMRI in TRAILBLAZER‐ALZ 6 Phase 3b study: Methodological considerations
Trial in peopleBiomarkers - AAIC 2025 Abstract
External Validation of Joint Propagation Model‐Based Tau PET CenTauR units
Study in peopleBiomarkers